BLACKROCK HEALTH SCI TR II (BMEZ)
$15.83
+0.04
(+0.25%)▲
Performance
- $15.81$15.96$15.83
0.1%
Downside
Day's Volatility :0.92%
Upside
0.81%
- $13.40$16.65$15.83
15.35%
Downside
52 Weeks Volatility :19.52%
Upside
4.92%
Returns
| Period | BLACKROCK HEALTH SCI TR II | Russel 2000 | Index (Russel 2000) |
|---|---|---|---|
3 Months | -0.5% | -6.7% | -6.7% |
6 Months | -0.25% | -3.7% | -3.7% |
1 Year | -5.32% | -6.3% | -6.3% |
3 Years | -21.56% | 26.9% | 26.9% |
Highlights
Market Capitalization | 1.7B |
Dividend Share | 0.0 |
Dividend Yield | 11.02% |
Earnings Per Share (EPS) | -5.9 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -5.9 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
BLACKROCK HEALTH SCI TR II is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 BLACKROCK HEALTH SCI TR II | -3.71% | -0.25% | -5.32% | -21.56% | -21.01% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
BLACKROCK HEALTH SCI TR II | NA | NA | NA | 0.0 | 0.0 | 0.0 | 0.11 | NA |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
BLACKROCK HEALTH SCI TR II | NA | $1.7B | -21.01% | NA | 0.0% |
Corporate Announcements
BLACKROCK HEALTH SCI TR II Earnings
BLACKROCK HEALTH SCI TR II’s price-to-earnings ratio stands at None
Read More
Company Information
BlackRock Health Sciences Trust II’s (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust’s risk-adjusted returns.
Organization | BLACKROCK HEALTH SCI TR II |
Employees | 0 |
CEO | Mr. Jeffrey Gene Lee |
Industry | Miscellaneous |
Discover More
Presto Automation Inc
$3.59
+63.93%
D-MARKET ELECTRONIC SERVICES
$1.04
+4.0%
Mexico MSCI Capped ETF iShares
$61.22
+2.03%
Global X S&P Catholic Values Developed ex-US ETF
$27.84
+0.0%
IndexIQ ETF Trust - IQ Chaikin U.S. Small Cap ETF
$30.75
+0.5%
DFA Dimensional Internatl High Profitability ETF
$24.08
+1.09%
Precigen Inc
$1.22
+1.67%
EXSCIENTIA PLC
$7.96
+1.14%
FIRST TRUST NASDAQ ARTIFICIA
$43.68
+2.68%